Search results for: Pricing and Reimbursement
Filter search results
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
14 April 2020
…systems and from the availability of treatments. These are over and above any value to the health system from decision makers having greater certainty about the benefits and costs of…
The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?
22 May 2020
…tests, treatments and vaccines will take time and requires rewarding the engagement of private sector research, development and manufacturing, as well using the resources and skills of government and of…
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…painfully reveals the broad and disastrous health, economic and societal impact of a highly infectious and potentially deadly disease for which there is, as yet, no vaccine. In addition to…
Does Government Funding Increase Public Sector Development of New Medicines?
5 March 2021
…The Pharmaceutical Industry and Global Health: Facts and Figures 2017. (downloaded from https://www.ifpma.org/wp-content/uploads/2017/02/IFPMA-Facts-And-Figures-2017.pdf) Barrenho, E. and Miraldo, M., 2018. R&D Success in Pharmaceutical Markets: A Duration Model Approach. In: Health…
OHE Innovation Policy Prize
18 May 2022
…the birth of health economics and has contributed to the development of novel theory and methodology, shaped the major policy and academic debates, and played a role in ultimately improving…
Science, Industry in the State
7 January 1965
…those with an interest in science-based industry, its economics, and its relationship with government; by civil servants, administrators and members of committees; and by all students of this important subject….
Innovation Balance of Payments: the Experience of the Pharmaceutical Industry
1 July 1967
…pattern of international pharmaceutical trade. The next two papers discuss the commercial considerations, such as profitability, pricing, use of brand names and sales promotion, which also affect an industry’s success…
Economics and Innovation the Pharmaceutical Industry
1 July 1969
…Health Economics was concerned to have the pricing policies and other behaviour of the pharmaceutical industry critically explored. Readers who are properly sceptical about the motives and inhibitions of a…
The Publicly Funded Vaccines Market in the UK
1 October 2010
…the UK. It includes observations as to whether and how the economic assessment process differs for vaccines compared to curative pharmaceutical products and the implications of the current pricing approach….